ATAZANAVIR
These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 2003
a40c4633-1808-4a28-b4af-769fb36da6c5
HUMAN PRESCRIPTION DRUG LABEL
May 15, 2023
Zydus Pharmaceuticals USA Inc.
DUNS: 156861945
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ATAZANAVIR
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (19)
ATAZANAVIR
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (21)
ATAZANAVIR
Product Details
FDA regulatory identification and product classification information